RT Journal Article
SR Electronic
T1 Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting
JF Canadian Family Physician
JO Can Fam Physician
FD The College of Family Physicians of Canada
SP e535
OP e540
VO 60
IS 11
A1 Vikas Srinivasan Sridhar
A1 Philemon Leung
A1 Nicole Seymour
A1 Jeff Nagge
YR 2014
UL http://www.cfp.ca/content/60/11/e535.abstract
AB Objective To describe the efficacy and safety of an initiation algorithm for 4 mg of warfarin in ambulatory patients with atrial fibrillation. Design Prospectively planned retrospective chart review. Setting Centre for Family Medicine Family Health Team in Kitchener, Ont. Participants Ambulatory patients requiring anticoagulation for atrial fibrillation. Interventions Patients were prescribed 4 mg of warfarin to be taken once daily for 3 days. An international normalized ratio (INR) measured on the morning of the fourth day was used to predict the maintenance dose of warfarin. Subsequent INR measurements were obtained biweekly until patients reached their actual maintenance dose. Main outcome measures Number of INR values greater than or equal to 4.0 before the warfarin maintenance dose was achieved. Secondary outcome measures included thromboembolic and bleeding events, number of days required to reach therapeutic INR, and correlation between predicted and actual warfarin maintenance dose. Results Twenty-five patients were included in the study. The average age was 76.0 years (range 56.0 to 89.0), and 17 patients were women. The average CHADS2 (congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, and stroke or transient ischemic attack) score was 2.0. Only 1 patient had an INR greater than 4.0 during the study period. The mean time to achieve a therapeutic INR was 11.0 days. The day 4 INR was moderately predictive of the maintenance dose (r2 = 0.47). There were no adverse events that required medical attention during the study period. Conclusion In this pilot study, an initiation algorithm for 4 mg of warfarin was safe and achieved a therapeutic INR within a reasonable time frame in outpatients with atrial fibrillation.